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A-to-I RNA editing, catalyzed by ADAR proteins, is
widespread in eukaryotic transcriptomes. Studies
showed that, inC. elegans, ADR-2 can actively deam-
inate dsRNA, whereas ADR-1 cannot. Therefore, we
set out to study the effect of each of the ADAR genes
on the RNA editing process. We performed compre-
hensive phenotypic, transcriptomics, proteomics,
and RNA binding screens on worms mutated in a sin-
gle ADARgene.We found that ADR-1mutants exhibit
more-severe phenotypes than ADR-2, and some of
them are a result of non-editing functions of ADR-1.
We also show that ADR-1 significantly binds edited
genes and regulates mRNA expression, whereas the
effect on protein levels is minor. In addition, ADR-1
primarily promotes editing by ADR-2 at the L4 stage
of development. Our results suggest that ADR-1 has
a significant role in the RNA editing process and in
altering editing levels that affect RNA expression;
loss of ADR-1 results in severe phenotypes.INTRODUCTION
Adenosine-to-inosine (A-to-I) RNA editing is a conserved pro-
cess in which adenosine deaminases that act on RNA (ADAR)
enzymes convert adenosine to inosine within double-stranded
regions of RNA (Bass, 2006). Inosine is read as guanosine by
the translation machinery and, thus, can change protein amino
acid content and function. Several examples of protein changes
in the human brain have been described (Burns et al., 1997; Pull-
irsch and Jantsch, 2010; Werry et al., 2008); however, most
editing sites in humans are in non-coding regions of the tran-
scriptome (mainly in Alu repeats) (Athanasiadis et al., 2004;
Barak et al., 2009; Blow et al., 2004; Kim et al., 2004; Levanon
et al., 2004; Li et al., 2009b). In mammals, ADARs are essential;
knockout mice are either embryonically lethal (ADAR1) or lethal1244 Cell Reports 27, 1244–1253, April 23, 2019 ª 2019 The Author(s
This is an open access article under the CC BY-NC-ND license (http://shortly after birth (ADAR2) (Wang et al., 2000; Higuchi et al.,
2000). However, in model organisms, such as C. elegans and
D. melanogaster, strains that lack all RNA editing are viable,
although they exhibit behavioral and anatomical defects (Tonkin
et al., 2002; Palladino et al., 2000).
Many A-to-I editing sites have been identified in theC. elegans
transcriptome by high-throughput RNA sequencing, andmost of
them are located in introns and other non-coding regions (Gold-
stein et al., 2017;Whipple et al., 2015;Wu et al., 2011; Zhao et al.,
2015). RNA editing in C. elegans is developmentally regulated.
The overall frequency of RNA editing is greater in embryos
than it is in other stages (Zhao et al., 2015). However, there are
genes that undergo frequent RNA editing at the L4 develop-
mental stage and almost no editing at the embryo stage, despite
the transcripts being expressed to a similar level in both stages
(Goldstein et al., 2017). This points to the fact that the editing
activity in C. elegans is highly regulated.
C. elegans possess two ADAR genes: adr-1 and adr-2. Both
proteins share the common ADAR enzyme structure: highly
conserved C-terminal deaminase domain and variable number
of N-terminal double-stranded RNA (dsRNA) binding motifs
(two double-stranded RNA-binding domain [dsRBD] in ADR-1
and one in ADR-2; Figure 1) (Tonkin et al., 2002). However,
ADR-2 is the only active adenosine deaminase in C. elegans,
as knockout of adr-2 abolishes all A-to-I RNA editing (Washburn
et al., 2014). On the other hand, ADR-1 acts as a regulator of
ADR-2, regulating editing efficiency by interacting with ADR-2
and with ADR-2 targets through its dsRNA binding domains
(Rajendren et al., 2018; Washburn et al., 2014). Expression anal-
ysis of GFP-tagged ADR-1 revealed that it is expressed mainly in
the nervous system and developing vulva, but expression occurs
in all developmental stages (Tonkin et al., 2002). Worms
harboring deletions in both adr-1 and adr-2 genes are viable
but have been reported to exhibit phenotypes that include
chemotaxis defects, altered life span, and decreased expression
of transgenes (Knight and Bass, 2002; Sebastiani et al., 2009;
Tonkin et al., 2002). Worms harboring a specific mutated adr-1
allele were also shown to have a mild protruding-vulva (Pvl)
phenotype (Tonkin et al., 2002).).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Schematic View of adr-1 and adr-2
Genes and Isoforms and the Deletions That
Were Used in This Study
The genes and known isoforms are represented in
their relative lengths. Double-strand RNA binding
motifs (dsRBMs) regions are shown in red, and the
deamination catalytic domains are shown in blue.
The deletion alleles (green) are scaled and posi-
tioned to reflect the area of deletion in the genes;
adr-1 gv6 (1,560-bp deletion) and tm668 (967-bp
deletion), adr-2 gv42 (1,013-bp deletion), and
ok735 (1,371-bp deletion). See also Figures S1 and
S2 and Data S1.Although thousands of editing sites were found in C. elegans
(Goldstein et al., 2017; Whipple et al., 2015; Wu et al., 2011;
Zhao et al., 2015), most of those sites are located in non-coding
regions and are, therefore, hard to link to the phenotypes of
ADAR mutant worms. A slight general reduction in expression of
C. elegans genes that undergo editing in 30 UTRs occurs in worms
harboringdeletions inbothadr-1and adr-2 (Goldstein et al., 2017);
however,mostof thosechangeswerenot directly linked topheno-
typic consequences. Recently, it was shown that the gene
clec-41, which is edited in the 30 UTR, is downregulated in neural
cells lacking adr-1 or adr-2. Furthermore, a reduction in clec-41
contributes to the chemotaxis defects of worms lacking adr-2
(Deffit et al., 2017). Interestingly, mutations in RNAi genes in
worms harboring mutations in adr-1 and adr-2 can rescue the
chemotaxis and life span phenotype of the worms (Sebastiani
et al., 2009; Tonkin andBass, 2003), implicatingRNAi involvement
in the RNA-editing function. However, the specific transcripts that
are important for those phenotypes and are altered by RNAi are
unknown. Furthermore, it is still unknown what the main function
of RNA editing is in C. elegans. There were some predictions of
changes in protein structure (Goldstein et al., 2017; Zhao et al.,
2015) caused by editing in coding regions of genes, although
thatwasshownononlyahandful ofgenes,and thechanges inpro-
tein structure were not validated. A new function for RNA editing
emerged from studies in mammals, in which mammalian ADAR1
was implicated in preventing aberrant activation of the innate
immune response from self-produced dsRNAs (George et al.,
2016; Liddicoat et al., 2015; Mannion et al., 2014). It is possible
that, in C. elegans, RNA editing has a similar function to prevent
protectionmechanisms, such asRNAi, in attacking self-produced
RNA (Ganem and Lamm, 2017; Reich et al., 2018). In that case,
the phenotypes observed in ADAR mutants might result from
changes in the RNA level and not necessarily in the protein level.
Many of the studies done so far onC. elegans examined pheno-
types, editing levels, and expression changes in worms harboring
mutations in both adr-1 and adr-2 genes (for example, Goldstein
et al., 2017; Tonkin et al., 2002; Whipple et al., 2015; Wu et al.,
2011; Zhao et al., 2015). Although some of these previous studiesCell Rindicated that a lack of either ADAR gene
resulted in chemotaxis and life-span
defects (Sebastiani et al., 2009; Tonkin
et al., 2002), ADR-1 probably affects the
expression and function of edited genes
and the severity of the phenotypesobserved in a different manner than ADR-2. In addition, ADAR
genes might have functions beyond RNA editing. For example,
in mice, ADARs were shown to affect splicing, independent of
their editing functionality (Solomon et al., 2013), and ADAR1 was
found to inhibit Staufen-mediated mRNA decay, independent of
its A-to-I editing function (Sakurai et al., 2017). To understand
the contribution of each of the C. elegans ADAR genes to the
RNA editing process, gene regulation, and the phenotypes ex-
hibited in ADAR-mutant worms, we performed a comprehensive
phenotypic, transcriptomics, and proteomics analysis on worms
harboring mutations in adr-1 or adr-2 separately. We found that
the phenotypes observed in adr-1 mutants are more severe,
and some are distinct from those we observed in adr-2 mutants.
We found that both genes affect the expression of edited genes,
but the effect of ADR-1 is much more prominent. Editing still
occurs in adr-1 mutants; however, the number of editing sites is
reduced significantly at the L4 developmental stage. In addition,
edited genes are also a significant portion of genes bound
by ADR-1 either directly or indirectly. These results implicate
ADR-1 as an important component of the RNA-editing process
and suggest that changes in the levels of editing cause more
developmental defects than does a complete lack of editing.
Our results also suggest that the main function of ADARs and
RNA editing is to regulate RNA expression and not the protein
content in a cell.
RESULTS
Previous studies suggested that ADR-1 is not necessary for the
editing process and is mostly a regulator of ADR-2 activity
(Rajendren et al., 2018; Tonkin et al., 2002; Washburn et al.,
2014). Editing is still observed in adr-1 mutants, although at
different levels (Tonkin et al., 2002; Washburn et al., 2014). To
explore the function of adr-1 and adr-2 in the editing process
separately, we performed phenotypic, transcriptomics, and pro-
teomics analyses on two deletion mutations for each gene. Both
deletions of the adr-2 gene—removing either the deaminase
domain or most of the protein (Figures 1 and S1; Tonkin et al.,eports 27, 1244–1253, April 23, 2019 1245
Figure 2. adr-1 and adr-2 Mutants Have
Opposite Life-Span Phenotypes
(A) The life span of the mutant worms was followed,
and the mean survival curves are presented for
N2 (wild type [WT]), adr-1(gv6)I, adr-1(tm668)I,
adr-2(gv42)III, adr-2(ok735)III, adr-1(gv6)I; adr-
2(gv42)III and adr-1(tm668)I; adr-2(ok735)III. Muta-
tions in adr-1 gene (adr-1(gv6)I or adr-1(tm668)I)
reduce the life span of thewormcomparedwith that
of the WT worms, whereas mutation in adr-2 gene
(adr-2(gv42)III or adr-2(ok735)III) extend the life
span of the worm compared with that of the WT
worms. Mutants for both genes have the same
pattern as the WT worms.
(B) The mean survival curves are presented for WT, adr-1 (tm668), and the rescue strains adr-1 (tm668) FLAG-ADR-1: adr-1(tm668) I blmEx1[ 3XFLAG-adr-1
genomic, rab3::gfp::unc-54] and adr-1 (tm668) FLAG-ADR-1 ds1+2 mutant: adr-1(tm668) I blmEx1 (3XFLAG-adr-1 genomic with mutations in dsRBD1 [K223E,
K224A, and K227A], and dsRBD2 [K583E, K584A, and K587A], rab3::gfp::unc-54). Both transgenic adr-1 rescue strains have life spans extended more than
adr-1(tm668). Each experiment was repeated at least five times.2002)—were expected to result in a non-functional protein. As
expected, we did not observe editing in mutants containing
either one of those deletions (Data S1). ADR-1 has five annotated
isoforms (Figure 1). Two isoforms are predicted to give rise to
truncated proteins that do not contain either the dsRNA-binding
domains or the deaminase domain. The dsRNA-binding
domains in ADR-1 were shown to be required to regulate editing
by ADR-2 (Rajendren et al., 2018; Washburn et al., 2014), and
both available deletions completely delete or disrupt the
dsRNA-binding domains (Tonkin et al., 2002; Washburn et al.,
2014). Indeed, we observed changes in the editing levels in
both deletion mutants, and as expected, editing was not
completely abolished (Data S1).
adr-1 Mutant Phenotypes Are More Severe Than Those
Observed in adr-2 Mutants
Worms harboring mutations in either or both adr-1 and adr-2
were previously shown to have reduced life-span and chemo-
taxis defects (Sebastiani et al., 2009; Tonkin et al., 2002). We,
therefore, sought to explore whether both genes contributed
equally to those phenotypes. If those phenotypes are a result
of abolished editing, we expected to observe the same pheno-
types in adr-2 mutants and, to a lesser extent, in adr-1 mutants.
Chemotaxis experiments that were done by Tonkin et al. (2002)
were repeated but with two deletion mutations for each of the
genes, instead of one. We received similar results, with all
mutants having chemotaxis defects (Figure S2). The chemotaxis
defects were restored to normal in transgenic worms harboring
FLAG-ADR-1 in an adr-1-mutant background (Washburn et al.,
2014) (Figure S2). These results are in line with a study that found
that both ADR-1 and ADR-2 affect expression of the clec-41
gene in neural cells, and overexpressing clec-41 in adr-2
mutants rescues the chemotaxis defect (Deffit et al., 2017). Inter-
estingly, we observed an upregulation of clec-41 in adr-1mutant
worms in the embryo stage, but not in the L4 stage and not in
adr-2mutants (see below). This upregulation was also observed
previously in L1 worms (Deffit et al., 2017). However, in neural
cells, clec-41 was shown to be downregulated in adr-1 mutants
(Deffit et al., 2017), suggesting that ADR-1 and ADR-2 may pro-
vide tissue-specific gene regulation in addition to development-
specific gene regulation.1246 Cell Reports 27, 1244–1253, April 23, 2019In addition, we performed life-span experiments on worms
with deletions in both adr genes and worms with a deletion in a
single adr gene. Strains harboring mutations in both adr-1 and
adr-2 had reduced life spans or life spans similar to wild-type
worms (Figure 2A). Surprisingly, we found that both deletion
strains of adr-1 significantly reduce life span, whereas both
strains with deletions in adr-2 significantly extended the life
span compared to wild-type worms (Figure 2A). Strains carrying
the extra-chromosomal array FLAG-ADR-1 in an adr-1-deletion
background were able to slightly rescue the life-span phenotype
of adr-1 mutation (Figure 2B). Interestingly, strains carrying a
FLAG-ADR-1 with mutation in the dsRNA-binding domains
(dsRBM) were able to rescue the life-span phenotype as well
as wild-type ADR-1, suggesting that either the ability of ADR-1
to promote life span is independent of dsRNA binding or,
possibly, mutant ADR-1 still has the ability to bind mRNAs other
than the edited mRNAs that were previously shown to have
disrupted ability to interact with the ADR-1 dsRBM mutant
(Washburn et al., 2014).
Previously, adr-1 was shown to be highly expressed in the
vulva, and one of the adr-1 deletion strains exhibited a slight
Pvl phenotype (Tonkin et al., 2002). To studywhether that pheno-
type is strain specific because of a second mutation in a close
gene or because of lack of adr-1, we counted the fraction of
worms with the Pvl phenotype in all strains. We found a signifi-
cant Pvl phenotype in all mutant strains, compared with wild-
type strains, although the phenotype fraction from total worms
was very low (less than 10% in all strains) (Figure 3A). ADR-1
mutants had the highest Pvl phenotype fraction, which was
significantly reduced in transgene worms with FLAG-ADR-1
and FLAG-ADR-1 with dsRBM mutations (Figure 3A). We
conclude that all ADAR mutants have developmental pheno-
types, although ADR-1 seems to be more important for normal
development than ADR-2 is.
We previously suggested that downregulation of genes in
ADARmutants could be a consequence of the antagonistic rela-
tionship between RNA editing and RNAi (Goldstein et al., 2017).
The possibility that ADAR genes and RNA editing itself are
antagonistic to the RNAi process was raised previously because
editing and RNAi both involve dsRNA substrates, because trans-
gene silencing was observed in ADAR double mutants, and
Figure 3. adr-1 Mutants Have High Frequency of Vulva Abnormalities
(A) ADAR-mutant strains were scored for pvl phenotype, and the fraction of worms presenting the phenotype from total worms is presented. The p value was
calculated with a two-sample, unequal-variance, heteroscedastic t test; *p < 0.01 compared with WT; Jp < 0.01 compared with adr-1(tm668)I.
(B)Wormswere subjected to lin-1RNAi. Multivulva phenotypes were scored at the first day of egg laying, and the fraction of worms exhibiting the phenotype from
total worms is presented. Each experiment was repeated at least three times, and the standard deviation is presented by error bars. The p value was calculated
with a two-sample, unequal-variance, heteroscedastic t test; *p < 0.01 compared with WT. NS, nonsignificant p value.
(C) Worms were subjected to unc-22 RNAi, and the fraction of worms presenting the bag of worms phenotype is presented. The p value was calculated by two-
sample, unequal-variance, heteroscedastic t test; *p < 0.01 compared with WT. Each experiment was repeated at least three times, and the standard deviation is
shown by error bars.because of changes in the amount of siRNAs generated in wild-
type worms and those lacking both ADARs (Goldstein et al.,
2017; Knight and Bass, 2002; Reich et al., 2018; Tonkin and
Bass, 2003; Warf et al., 2012; Whipple et al., 2015; Wu et al.,
2011). Hypersensitivity to exogenous RNAi is a phenotype
related to the ERI/RRF-3 endogenous RNAi pathway (Simmer
et al., 2002), which is also reflected by transgene silencing.
Therefore, hypersensitivity to RNAi was previously tested in
several ADAR mutants (Knight and Bass, 2002; Ohta et al.,
2008), which did not show hypersensitivity. We tested hypersen-
sitivity to RNAi in all ADAR single and double mutants by
triggering exogenous RNAi by feeding the worms with bacteria
producing dsRNA against lin-1 or unc-22 genes (Simmer et al.,
2002) and scoring the phenotype. We did not observe high
enrichment of the multivulva phenotype in all ADAR mutant
worms as compared with wild type when triggering RNAi against
lin-1 (Figure 3B). As expected, rrf-3 mutant worms, which are
hypersensitive to RNAi, have a significantly high fraction of the
phenotype (Figure 3B). Triggering unc-22 RNAi, we expected a
twitching phenotype, and in observing a strong twitching pheno-
type, we also noticed a new phenotype of the bag of worms (Fig-
ure 3C). The bag of worms phenotype was observed in a high
fraction in adr-1 mutant worms and, to a lesser extent, in the
adr-1;adr-2 double mutants and in adr-2 mutants. This pheno-
type is not a result of hypersensitivity to RNAi because it was
not enriched in rrf-3 mutants (Figure 3C). We conclude that this
bag of worm phenotype and the pvl phenotype are specific to
adr-1 and might be a result of a different function of ADR-1,
distinct from RNA editing.
Both ADR-1 and ADR-2 Affect Expression of Genes
Edited at Their 30 UTR
Previously, we demonstrated that the expression of genes with
edited 30 UTRs is slightly reduced in worms harboring deletions
in both ADAR genes (Goldstein et al., 2017). The list of genes
that are edited at their 30 UTR was based on a screen for editingsites in non-repetitive regions in the transcriptome. In total, 77
genes with 30 UTR-edited sites were identified (Goldstein et al.,
2017). However, many edited sites were not included in the
list, even though they are in a very close proximity to the 30
UTR annotation of genes. These include genes that were bio-
chemically identified by others to be edited at their 30 UTR, for
example, alh-7 and C35E7.6 (Morse et al., 2002; Morse and
Bass, 1999). To extend the list of genes edited at their 30 UTR,
we manually annotated the edited sites in non-repetitive regions
that are in proximity to genes. We added to the list, genes in
which multiple editing sites are in the same orientation as the
gene and in very close proximity to their annotated 30 UTR or
within the 30 UTR, based on the newest version of Wormbase
(see STAR Methods). Overall, we added 58 genes, and the list
now includes 135 genes (Table S1). To re-examine the conclu-
sion regarding expression levels of genes edited in 30 UTRs in
worms harboring deletions in both adr-1 and adr-2, we reana-
lyzed the expression data from Goldstein et al. (2017). We
observed similar results with the 135 genes; their expression
levels were slightly reduced compared with all genes in both
embryo and L4 developmental stages (p < 0.003 calculated
by Welch two-sample t test analysis for genes with a padj
value < 0.05), suggesting that the newly identified genes edited
in 30 UTRs are bona fide ADAR-regulated genes (Figure S3).
To studywhether the expression levels of 30 UTR-edited genes
are affected in the single-deletion mutants, we generated RNA
sequencing (RNA-seq) data from three biological replicates of
each of the strains and the wild-type strain in the embryo
and L4 developmental stages. We observed the tendency for
reduced expression of 30 UTR-edited genes in all adr-1 and
adr-2 mutants in the embryo stage (Figures 4A and 4B; p <
2.2e16 for adr-1 (gv6), p = 0.002 for adr-1 (tm668), p < 0.002
for adr-2 (gv42), and p = 2.5e05 for adr-2 (ok735)). However,
the expression of 30 UTR-edited genes does not change in all
single-ADAR mutants in the L4 developmental stage (Figures
4C and 4D). This is in contrast to what we observed before inCell Reports 27, 1244–1253, April 23, 2019 1247
Figure 4. Genes Edited at Their 30 UTR Are
Downregulated in adr-1 and adr-2 Mutants
at the Embryo Stage
Log-scale plots presenting gene expression in
wild-type (N2) worms versus adr-1 mutant worms
(A and C) or adr-2 mutant worms (B and D) at the
embryo stage (A and B) and at the L4 stage (C and
D). Every dot in the graphs represents a gene. Red
line is the regression line for all genes. The 30
UTR-edited genes with significant padj value are in
purple, and their regression line is presented in
purple. Downregulated genes found by the prote-
omics analysis are in orange, and upregulated
genes are in green. Alh-7 gene is downregulated in
adr-1 mutants at the embryo stage in all analyses
(blue in A). Adbp-1 gene is downregulated in adr-2
mutants in all analyses at the embryo stage
(orange in B). See Figures S3, S6, and S7 and
Tables S1, S2, and S5.the double mutants (Goldstein et al., 2017). Thus, the effect of
ADAR mutations on the expression of 30 UTR-edited genes is
stronger in the embryo stage than in the L4 developmental stage.
ADR-1 Affects the Expression of Edited Genes
To further explore the expression of genes in adr-1 and adr-2
mutants, we identified the genes with a 2-fold or greater change
in expression and a significant adjusted p value after Benjamini-
Hochberg correction in each of the single-ADARmutants in each
developmental stage. We further shortened the list by including
only genes that were significantly differentially expressed in
both deletion mutations for each gene (Table S2) to avoid
allele-specific background effects on gene expression. We
found more upregulated than downregulated genes in both
ADARmutants in all developmental stages (Table S2) with signif-
icant overlap (p < 0.01 calculated by hypergeometric distribution
and by the chi-square test) of differentially expressed genes be-
tween the embryo and L4 developmental stages (Figure S3).
There is also a very significant overlap (p < e5) between differ-
entially expressed genes in adr-1 mutants and adr-2 mutants
in all stages (Figure S4). However, 30 UTR-edited genes were
not a substantial part of the differentially expressed genes in
either ADAR mutants (p value not significant; Figure S4). To
explore whether genes edited in regions other than the 30 UTR
are differentially expressed in ADAR mutants, we compared
the genes differentially expressed in each ADAR mutant and
genes edited at the embryo or L4 developmental stages
(described in Goldstein et al., 2017). We did not find a significant
overlap between differentially expressed genes in adr-2mutants1248 Cell Reports 27, 1244–1253, April 23, 2019and genes edited at L4 or at embryo
stages (non-significant p value; Fig-
ure S4). Surprisingly, a significant portion
of the upregulated genes in adr-1mutants
were genes edited at the L4 stage (p <
0.01; Figure 5). Downregulated genes in
adr-1 mutants were not enriched for edi-
ted genes (non-significant p value; Fig-
ure 5). These results suggest that adr-1not only affects the level of editing but also the expression of
edited genes.
ADR-1 Role in Regulating RNA Editing Is Stronger at the
L4 Stage
The increased expression of edited genes and the alterations in
editing levels in adr-1 mutants suggests that ADR-2 editing of
these genes is assisted by ADR-1 andmay be important to stabi-
lize gene expression. As for the lack of connection between the
downregulated genes in the adr-1 mutant worms and editing in
wild-type worms, it is possible that these downregulated genes
contain editing sites in the adr-1 mutants and not in wild-type
worms. This would suggest that ADR-1 also has a role in binding
RNA and protecting or preventing the RNA from the editing by
ADR-2. Therefore, newedited sites, ‘‘theprotected sites,’’ should
emerge in the high-throughput sequencing data sets obtained in
the absence of ADR-1. To test that hypothesis, we performed a
screen to identify editing sites in adr-1 mutants, similar to Gold-
stein et al. (2017), with the difference that only nucleotide
changes that appeared in both adr-1mutant alleles were consid-
ered.When counting the number of nucleotide changes thatwere
identified in adr-1 mutants, surprisingly, we found a significant
reduction in the amount of editing sites identified in adr-1mutants
at the L4 developmental stage compared with the embryo stage
(Figure 6A; p < 0.01 calculated by Fisher exact test; Table S3).
Next, we tested whether there are editing sites in adr-1 mutants
that are not present in wild-type worms by comparing the lists
of nucleotide changes. Although the number of editing sites
that are only present in adr-1 mutants was not above the
Figure 5. Significant Portions of Genes That
Are Edited at L4 Stage Are Upregulated in
adr-1 Mutants
Venn diagrams presenting the intersections be-
tween edited genes at the embryo or L4 develop-
mental stages, and (A) genes with their expression
downregulated at embryo stage in adr-1 mutants.
(B) Genes with their expression downregulated at
the L4 stage in adr-1 mutants.
(C) Genes with their expression upregulated at
embryo stage in adr-1 mutants.
(D) Genes with their expression upregulated at the
L4 stage in adr-1 mutants.
See Figure S4.background of the other nucleotide changes at the L4 stage, we
found an enrichment of editing sites that are present only in the
adr-1 mutants at the embryo stage (Figure 6A; Table S3). To
further study those sites, we compared genes with editing sites
that areonly edited inadr-1mutants at theembryo stage to edited
genes found inwild-typeworms.We found thatmost of the genes
with editing sites unique to adr-1mutants haveother sites that are
edited inwild-typeworms (Figure 6B). In addition, these genesdo
not have a significant change in expression in adr-1mutants (Fig-
ures 6C and 6D). Overall, these results suggest that ADR-1 does
not protect the dsRNA frombeing edited byADR-2but, rather, di-
rects and enhances ADR-2 editing, especially at the L4 develop-
mental stage. This is in linewith our findings thatmany genes that
are upregulated in adr-1mutants are only edited at the L4 devel-
opmental stage (Figure 5).
ADR-1 Binds Edited Genes
To study whether ADR-1 affects the expression of genes by bind-
ing their RNA, we performed an RNA immunoprecipitation assay
on young adult worms using the FLAG antibody and worms ex-
pressing the FLAG-1:ADR-1 transgene or worms lacking adr-1
as a negative control. The bound RNAs were extracted, and
poly(A) was selected and sequenced by high-throughput
sequencing (RIP-seq; Table S4). Almost one-third of the 30 UTR-
edited genes are bound by ADR-1 (Figure S5), and a significant
portion of edited genes, in general, as determined by the hyper-
geometric distribution test (p < e44; Figure 7). These results
confirm that ADR-1 regulates edited genes by binding their
RNA either directly or through a common, interacting RNA-
binding protein. Interestingly, we found that ADR-1 binds
unc-22, which has an important role in the regulation of the
actomyosin dynamics (Benian et al., 1989), and unc-54, which en-
codes a muscle myosin class II heavy chain (Waterston, 1989).
Mutations in unc-54 can suppress the twitching phenotype ofCell Runc-22, which suggests an interaction be-
tween those genes (Moerman et al., 1982).
Thus, the new bag of worms phenotype
that we observed when adr-1 mutant
worms were subjected to unc-22 RNAi
(Figure 3B) suggests a function for ADR-
1 in muscle formation. This function is
probably distinct from the function of
ADR-1 in RNA editing because we didnot find editing in unc-54 RNA, and unc-22 only has one editing
site in an intron. In addition, this phenotype is not as significant
in adr-2 mutants.
RNAEditing DoesNot Affect the Protein Levels of Edited
Genes
To study whether the changes in RNA levels of genes in ADAR
mutants affect their protein levels as well, we performed a com-
parison between the proteome content of wild-type worms and
adr-1- or adr-2-mutant worms at the embryo or L4 develop-
mental stages (Table S5). We extracted proteins from three bio-
logical replicates of each strain, trypsinized the proteins, and
quantified them by mass spectrometry (see STAR Methods).
These experiments identified 5,984 proteins in total; 1,426
were only identified in the embryonic samples, and 1,333 were
specific to the L4 stage. Although there was a significant repre-
sentation of edited genes in the proteomics analysis (Figure S6;
p < e4 for all groups of edited genes), the protein levels of
only 22 genes were significantly changed in ADAR mutants (Ta-
ble S5). Of the 22 genes in which protein levels changed in both
adr-1 mutant strains or in both adr-2 mutants strains (not
including ADAR genes themselves), four genes were also found
to be edited,C06A5.6,W07G4.3, Y54E2A.4, and alh-7. These re-
sults are not surprising because most of the editing sites are in
non-coding regions (Goldstein et al., 2017), and many of the edi-
ted genes in human and C. elegans as well are probably not
protein-coding genes. Interestingly, alh-7, which undergoes ed-
iting at its 30 UTR and is a highly conserved neuronal gene (Morse
et al., 2002), was significantly downregulated in adr-1 mutants
both at the RNA level and the protein level at the embryo stage
(Figure 4). Another interesting gene is adbp-1, which is a regu-
lator of adr-2 (Ohta et al., 2008). ADBP-1 was shown to interact
with ADR-2 and facilitate its cellular localization (Ohta et al.,
2008). We found that the protein level of adbp-1was significantlyeports 27, 1244–1253, April 23, 2019 1249
Figure 6. Most of the Editing Sites That Appear Only in adr-1 Mutants Are in Genes with Editing Sites in Wild-Type Worms
(A) A bar graph representing nucleotide changes found in wild-type and adr-1 mutant worms at the L4 and embryo developmental stages. Also presented are
nucleotide changes that were found in adr-1 mutants but not in wild-type worms.
(B–D) Venn diagrams presenting the intersection between genes with editing sites that were detected in adr-1 mutants and not in wild-type worms and
(B) Genes edited in wild-type worms at the embryo or L4 developmental stages.
(C) Genes with their expression upregulated or downregulated at the embryo stage in adr-1 mutants.
(D) Genes with their expression upregulated or downregulated at the L4 stage in adr-1 mutants.
See Table S3.downregulated in both adr-2 mutants but not the mRNA levels
(Figure 4; Tables S2 and S4), whereas ADR-2 protein was also
significantly downregulated in the adbp-1 mutant (Figure S7).
These results suggest that the regulation between ADR-2 and
ADBP-1 is not unidirectional but that both proteins regulate
each other’s stability.
DISCUSSION
In this work, we performed a comprehensive phenotypic, tran-
scriptomics, and proteomics analysis on the two ADAR genes
in C. elegans to explore their individual role in the RNA-editing
process. We confirmed that ADR-2 is the only active enzyme
but found that ADR-1 regulates not only the editing process
but also the expression of edited genes. This comprehensive
analysis was performed on two different deletion alleles for
each ADAR gene to rigorously identify the effects of each
ADAR and to avoid allele-specific bias.
ADR-1 Has Distinct Phenotypes and Likely Distinct
Functions from ADR-2
The analysis revealed several interesting abnormal phenotypes,
some of which are specific to adr-1 mutants. The aberrant
chemotaxis phenotype that was previously described (Tonkin
et al., 2002) was apparent in all ADAR mutants (Figure S2) and
was rescued by an ADR-1 transgene. The expression of the edi-
ted gene clec-41 in neuronal cells was shown to be important for
that phenotype (Deffit et al., 2017). This suggests that the
absence or changes in the levels of editing in specific genes
causes the aberrant chemotaxis phenotype. The decrease in
the life span was previously observed in worms harboring muta-
tions in either adr-1 or adr-2 genes or both (Sebastiani et al.,
2009). When we examined life span of worms harboring the
single mutants, we found that the two ADAR genes contribute1250 Cell Reports 27, 1244–1253, April 23, 2019to the life span of the worms in the opposite direction. The
changes in editing levels in ADAR mutants might produce
these phenotypes. One possibility is that, when editing is absent
in adr-2 mutants, the worms live longer, and when editing levels
are reduced or even elevated in specific genes in adr-1mutants,
it causes a reduction in life span. As a decrease in the life span
is a very common phenotype in C. elegans, and reduced
expression of many edited genesmay cause a similar phenotype
(Goldstein et al., 2017; Zhao et al., 2015), it is hard to pinpoint a
particular gene that underlies this phenotype. We only observed
a partial rescue of the life span decrease by expressing trans-
genic adr-1, probably because of insufficient expression of the
transgene in the germline and early embryonic cells because
the transgene is expressed from an extra-chromosomal array
that limits expression in the germline. Thismay also be the reason
why transgenic ADR-1 with mutations in the dsRNA-binding do-
mains rescues to the same degree as the wild-type transgenic
ADR-1. It is also possible that the different life-span phenotypes
in adr-1 and adr-2 are a result of distinct functions of these genes,
which might not be related to RNA editing of one specific gene.
The pvl phenotype seems to be specific to adr-1 mutants, as
suggested before (Tonkin et al., 2002), although in a very low
penetrance. This phenotype was not allele specific because we
observed it in two different alleles and we could partially rescue
this phenotype with adr-1 transgenes. Another phenotype that
seems to be specific to adr-1 mutants is the bag of worms
(BOW) phenotypes when the mutant worms are subjected to
unc-22 RNAi. Both phenotypes, pvl and BOW, are probably
related to each other. adr-1, unc-22, and unc-54 are expressed
in the vulva (Moerman et al., 1988; Tonkin et al., 2002) and bind
to each other. Because unc-22 and unc-54 do not appear to be
regulated by RNA editing, these phenotypes are probably not
related to RNA editing and possibly ADR-1 has other functions
not related to RNA editing, including regulating vulva formation.
Figure 7. ADR-1 Binds Edited Genes
Venn diagrams presenting the intersections be-
tween edited genes, genes identified as bound by
ADR-1 using RIP-seq analysis and
(A) Genes that their expression is downregulated at
embryo stage in adr-1 mutants.
(B) Genes that their expression is downregulated at
L4 stage in adr-1 mutants.
(C) Genes that are upregulated at the embryo stage
in adr-1 mutants.
(D) Genes that are upregulated at the L4 stage in
adr-1 mutants.
See Figure S5 and Table S4.In general, adr-1mutant phenotypesaremore severe than adr-2
phenotypes, and the double-mutant phenotypes seem to be the
middle ground between the phenotypes of the two single muta-
tions formostphenotypes. Thus, it is likely that changes in the edit-
ing levels are more harmful than a complete loss of editing.
RNA Editing Process Is Highly Regulated
Our results show that ADR-1 has a significant effect on edited
genes. We found that there is a decrease in the overall expres-
sion level of genes editedwithin 30UTRs, that ADR-1 binds edited
genes, and that a significant portion of upregulated genes in
adr-1 mutants are genes edited at the L4 stage. Moreover, we
found that the effect of ADR-1 on editing is stronger at the L4
developmental stage than it is at the embryo stage. Thus,
ADR-1 can both upregulate and downregulate the expression
of edited genes, and that might depend on the level of editing
in a specific gene or even a specific site within a gene.
ADR-1 does not have deamination activity and was suggested
to regulate editing by binding to ADR-2 targets and facilitating or
preventing ADR-2 activity (Washburn et al., 2014). Indeed, we
observed that a very significant portion of ADR-1 binding targets
are edited genes. The RIP-seq experiments that we performed
do not exclude indirect binding to edited genes; however, the
RNA binding domains in the ADR-1 protein were shown to have
an important role in editing regulation (Rajendren et al., 2018;
Washburn et al., 2014). When we used a mutated version of
ADR-1-FLAG with mutations in the RNA-binding domain, the
rescue of the vulva and life-span phenotypes was similar to that
of the strain expressing the wild-type ADR-1-FLAG transgene.
Although Washburn et al. (2014) demonstrated that ADR-1 with
mutations in both dsRNA-binding domains cannot bind several
edited genes by RIP experiments coupled to qPCR, it is possible
that the mutated ADR-1 lacks the ability to bind ADR-2 targetsCell Rbut can bind other mRNAs. Another hy-
pothesis is that some of adr-1mutant phe-
notypes are not related to the ADR-1 func-
tion in editing. Therefore, it is possible that
the RNA-binding domains are needed for
ADR-1 function in editing, and the inactive
deamination domain has evolved to
perform other ADR-1 functions, such as in
muscle formation.
By detecting edited sites that occur
only in adr-1 mutants, we found thatthe effect of ADR-1 on editing is more significant at the L4
developmental stage than it is in the embryo stage. This result
goes well together with our findings that the expression of
several edited genes is also upregulated in adr-1 mutant worms
(Figure 5) and that the phenotypes observed in adr-1 mutants
are associated with more-advanced stages of development.
These results suggest that the main function of ADR-1 is regu-
lating editing by ADR-2 at the L4 stage. We found that most of
the editing sites that are unique to adr-1 mutants at the embryo
stage are in genes that undergo editing at other sites in wild-
type worms. It is possible that these sites were not detected
in wild-type worms because of the restriction of at least 5% ed-
iting in the analysis. It was shown that ADR-1 can both enhance
and reduce the levels of editing (Washburn et al., 2014); there-
fore, these sites might appear only in adr-1 mutants because
their editing level was enhanced enough to cross the threshold.
This, together with the absence of unique editing sites in the
adr-1 mutants leading to altered gene regulation, indicates
that ADR-1 primarily promotes editing and does not prevent
ADR-2 binding to specific sites and editing to result in altered
gene expression.
Not many regulators of RNA editing are known in
C. elegans. Only one protein, other than ADR-1, was also
shown to regulate editing. That protein, ADBP-1 (ADR-2 bind-
ing protein-1), was previously shown to alter ADR-2 nuclear
localization (Ohta et al., 2008). We found that both ADR-2
and ADBP-1 regulate each other’s protein levels. It is not clear
how ADR-2 affects ADBP-1; however, it seems to be affected
at the protein level because the RNA expression of adbp-1 is
not affected in adr-2 mutants. Other editing regulators might
also be involved, regulating editing in a developmental-spe-
cific, tissue-specific, and cellular-specific manner (Ganem
and Lamm, 2017).eports 27, 1244–1253, April 23, 2019 1251
TheMajor Role of RNA Editing Is to Regulate RNA Levels
and Not Protein levels
In our previous study (Goldstein et al., 2017), we found that the
level of expression in genes edited at their 30 UTR is slightly, but
significantly, less in worms mutated in adr-1 and adr-2,
compared with wild-type worms. In this study, we also
observed that reduction in gene expression in the single-
ADAR mutants at the embryo stage. Hundreds of genes were
2-fold upregulated and downregulated at the RNA level in the
single-ADAR mutants, and there was a significant portion of
L4-edited genes in adr-1 upregulated genes. However, only
22 genes had a significant change in protein levels in adr-1 or
adr-2 mutant worms. From them, only four genes were found
to be edited (Goldstein et al., 2017), even though there was a
high representation of edited genes in the proteomics data.
Recently, RNA editing was shown to have an important part in
suppressing the innate immune response in mammals (George
et al., 2016; Liddicoat et al., 2015; Mannion et al., 2014) by
marking self-produced dsRNA, which prevented endogenous
dsRNA from triggering the immune response. It is possible
that RNA editing has a similar function in C. elegans, e.g.,
marking self-dsRNA to prevent the immune response (RNAi)
from processing and degrading the RNA (Reich et al., 2018; Ga-
nem and Lamm, 2017). In addition, most of the edited sites in
mammals and in C. elegans are in non-coding regions (for
example, pseudogenes, intergenic regions, and transposons)
(Athanasiadis et al., 2004; Barak et al., 2009; Blow et al.,
2004; Goldstein et al., 2017; Kim et al., 2004; Levanon et al.,
2004; Li et al., 2009b; Warf et al., 2012; Wu et al., 2011). Thus,
probably the main function of RNA editing in C. elegans is not
to alter the content of the proteins in the cell but rather to buffer
other processes, such as RNAi.STAR+METHODS
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RNeasy Extraction Kit QIAGEN, Hilden, Germany N/A
SuperScriptIII Invitrogen Cat# 18080093
Deposited Data
Raw and analyzed data This paper GEO: GSE110701
Experimental Models: Organisms/Strains
C. elegans: Strain Bristol N2 Caenorhabditis Genetics Center Tonkin et al., 2002
C. elegans: Strain BB2: adr-1 (gv6) I Caenorhabditis Genetics Center Tonkin et al., 2002
C. elegans: Strain BB3: adr-2 (gv42) III Caenorhabditis Genetics Center Tonkin et al., 2002
C. elegans: Strain BB4: adr-1 (gv6) I; adr-2 (gv42) III Caenorhabditis Genetics Center Tonkin et al., 2002
C. elegans: Strain BB19: adr-1 (tm668) I Caenorhabditis Genetics Center Hundley et al., 2008
C. elegans: Strain RB886: adr-2 (ok735) III Caenorhabditis Genetics Center Hundley et al., 2008
C. elegans: Strain BB21: adr-1 (tm668) I; adr-2 (ok735) III Caenorhabditis Genetics Center Hundley et al., 2008
C. elegans: Strain QD1: adbp-1(qj1) II Caenorhabditis Genetics Center Ohta et al., 2008
C. elegans: Strain HH76: adr-1(tm668) I blmEx1[3XFLAG-adr-1
genomic, rab3::gfp::unc-54]
Washburn et al., 2014
C. elegans: Strain HH116: adr-1(tm668) I blmEx1[3XFLAG-adr-1
genomic with mutations in dsRBD1 (K223E, K224A, and K227A)
and dsRBD2 (K583E, K584A and K587A), rab3::gfp::unc-54]
Washburn et al., 2014
C. elegans: Strain HH134: adr-1(tm668);adr-2(ok735) I
blmEx1[3XFLAG-adr-1 genomic, rab3::gfp::unc-54]
Washburn et al., 2014
Oligonucleotides
F48E8.4 Forward 50 - CTTCTAGTCCCGCCAAATTTATG - 30 This study N/A
F48E8.4 Reverse 50 – CAGTTGAAGTTATTCCACGACCC - 30 This study N/A
rncs-1 Forward 50 – ATTTTTTCCCGACAAAGATGGAACTC
AAGGAT – 30
This study N/A
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
rncs-1 Reverse 50 – TGATTCAACATTTCAAAAACTTGTATT
TTACATCTAAAACTATAAA – 30
This study N/A
AL_SD_1 adr-1(gv6) forward: CAATGTCGCAAAACCAAATG This study N/A
AL_OBN_132 adr-1(gv6) reverse: GAGATGTTCCATTGGCTCC This study N/A
AL_SD_3 adr-2(gv42) forward: AAGGAAAGAACGCATTGGTG This study N/A
AL_SD_4 adr-2(gv42) reverse: GTTTCTCAGCTCCAGGCATC This study N/A
AL_SD_7 adr-1(tm668) forward: CCAGGGTTGGA
TCCTCTCGGTG
This study N/A
AL_SD_8 adr-1(tm668) reverse: GTCACGAAG
AGCTTCACGAATGACC
This study N/A
AL_SD_6 adr-2(ok735) forward: AGCCTGAGCTCG
CTTCCAATCTTCAAG
This study N/A
AL_SD_5 adr-2(ok735) reverse: CCCCCAGCTTACAGT
AATCATCAGTTCTGCC
This study N/A
HH1944:GTAATTTATTTGACTACGAAATGGATC This study N/A
HH1945:TCCAATTTGGTTTGTTTTGG This study N/A
HH1948:CTCTCGGCATATTTCCTCTATATTG This study N/A
HH1949: TGTCCATAACCGAAGTTGTAGTTAG This study N/A
HH1952: AGGTAATTTATTTGACTACGAAATGGATC This study N/A
HH1953:TTATTTTGCGAAATTGTTGTTACG This study N/A
HH1954: CGACTCCATCCAGATTGTG This study N/A
HH1955:GTTTCCTTAAATAATATTCAACTCCG This study N/A
Recombinant DNA
Plasmid:unc-22 (RNAi) Kamath et al., 2001 N/A
Plasmid:lin-1 (RNAi) Kamath et al., 2001 N/A




Bowtie Langmead et al., 2009 http://bowtie-bio.sourceforge.net/
index.shtml
DESeq package in R Anders and Huber, 2010 https://bioconductor.org/packages/
release/bioc/html/DESeq.html
Samtools Li et al., 2009a http://samtools.sourceforge.net/
MaxQuant 1.5.2.8 (Cox and Mann, 2008;
version 1.5.2.8)
N/A
LC-MS/MS on Q Exactive plus Thermo N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for reagents may be directed to and will be fulfilled by the Lead Contact, Ayelet Lamm (ayeletla@
technion.ac.il).
EXPERIMENTAL MODEL AND SUBJECT DETAIL
Maintenance and handling of C. elegans strains
Worm strains are described in the Key Resources Table. All strains were grown at 20C on NGM agar media with OP50 as food as
described in Brenner (1974). The genotype of each of the strains was validated by PCR and sequencing before use. Embryos were
isolated from adult worms by washing wormswith M9 and sodium hypochloride. To collect L4 worms, embryos were left overnight in
M9 in a nutator at 20C and the hatched synchronized L1 larva were placed on NGM agar plate until they reached the L4 larva stage.
L4 developmental stage was confirmed using binocular, by measuring 650 mm in length. Embryos or L4 larva worms were
resuspended in either M9 for proteomic analysis or EN buffer for RNA extraction and frozen into pellets with liquid nitrogen. Only
fluorescent worms were counted for every experiment that used strains HH76, HH116, and HH134.Cell Reports 27, 1244–1253.e1–e4, April 23, 2019 e2
METHOD DETAILS
Lifespan assay
Synchronized L1 wormswere plated and kept at 15C, until they reached L4 stage (after about 48 hours). L4 worms from each tested
strain were transferred to 5 FUdR plates, about 50 worms per plate. FUdR was added to the NGM agar before pouring the plates, to
a final concentration of 4.95 mM, in order to prevent the worms from having progeny. Live and dead worms were counted every
2-4 days. A worm was considered dead when it did not respond to touch of the platinum wire pick, and was subsequently removed
from the plate. Worms that crawled over the edges of the plates and dried out were reduced from the total count. At least three
biological replicates were performed for each experiment.
Assays for Bag of worms Phenotype, vulva abnormalities, and hypersensitivity in worms
To perform RNAi, unc-22 (Kamath et al., 2001) or lin-1 (Kamath et al., 2003) or empty L4440 plasmids were transformed into E. coli
HT115 bacteria and were cultured overnight at 37C in LB media containing 100 mg/ml ampicillin. The cultured bacteria were seeded
onto C. elegans growth media plates (NGM) containing 100 mg/ml ampicillin and 10 mg/ml IPTG and incubated overnight at RT over-
night. Synchronized embryos were placed on the plates and incubated for 72-96 hours at 20C before scoring. Worms were then
scored using Nikon SMZ745 zoom stereomicroscope for PVL, BOW, or Multivulva phenotype. Worms presenting the phenotypes
were counted in relative to the total number of worm in each plate. In the RNAi experiments the fraction of worms presenting the
phenotype in the empty vector experiment was subtracted from the fraction of worms presenting the phenotype in the unc-22 or
lin-1 RNAi experiments.
DNA and RNA Sanger sequencing
To obtain cDNA, extracted RNA (MirVana) was treated with DNase I (Ambion) and then a reverse transcriptase reaction was per-
formed with SuperScriptIII (Invitrogen), using 6-mer random primers. DNA was extracted using Phire Tissue Direct PCR Master
Mix (Thermo Scientific). The amplification products were directly sequenced by Sanger sequencing.
Isoforms validation
Presence of ADR-1 isoforms in different worm strains was assessed via PCR amplification of cDNA from adult worms of strains N2,
adr-1(gv6), adr-2(gv42), adr-1(gv6);adr-2(gv42), adr-1(tm668), adr-2(ok735), and adr-1(tm668); adr-2(ok735). RNA was isolated from
whole worms using Trizol (Invitrogen) followed by DNase (Fisher Scientific, Hampton, NH) treatment, and purification using the
RNeasy Extraction Kit (QIAGEN, Hilden, Germany). cDNA was synthesized from 2ug of whole worm RNA using Superscript
III(Invitrogen) along with random hexamers (Fisher Scientific) and oligo-dT (Fisher Scientific) primers. Amplification of the different
isoforms was carried out using Platinum PFX DNA Polymerase and 3ul of cDNA from each strain. ADR-1 isoform C was amplified
using primers HH1944 and HH1945. ADR-1 isoform E was amplified using primers HH1948 and HH1949. ADR-1 isoform G was
amplified using primers HH1952 and HH1953. ADR-2 was amplified using primers HH1954 and HH1955.
Chemotaxis Assay
Adult worms were used to assess chemotaxis behavior similarly to what was performed in Deffit et al. (2017). Chemotaxis to benz-
aldehyde (1:1000 dilution in ethanol) and trimethylthiazole (1:10,000 dilution) was assessed and chemotaxis index determined using
the formula in Deffit et al. (2017) . Three replicate plates for each worm strain were used in each of the 5-9 biological replicates.
Western analysis
Plates of starved worms were chunked onto 15 cm plates and allowed to grow for 3 days, with additional food added at day 2 to
prevent starvation. Worms were collected from NGM plates using 1X M9 buffer (0.04 M Na2HPO4, 0.02 M KH2PO4, 0.009 M
NH4Cl, 0.02 M NaCl), washed with extract buffer (50 mM HEPES [pH 7.4]; 70 mM K-Acetate, 5 mM Mg-Acetate, 0.05% NP-40,
and 10% glycerol) and frozen at 80C. A cold motor and pestle were used to make worm lysates from the frozen pellets. The total
protein concentration of the lysates was quantified using a Bradford assay (Sigma-Aldrich) and an equivalent amount of lysates from
each strain were subjected to SDS-PAGE and immunoblotting with a custom ADR-2 antibody (described in Deffit et al., 2017) and an
antibody to b-actin (Cell Signaling Technology).
mRNA-seq libraries preparation
Embryos and L4 worms frozen pellets were grounded to powder with a liquid nitrogen chilled mortar and pestle. RNA in high and low
molecular weight fractions was extracted by mirVana kit (Ambion). RNA sequencing libraries were prepared from the high molecular
weight fraction using the SMARTer Stranded RNA-Seq Kit (Clontech Laboratories) after ribosomal depletion by Ribozero kit
(Epicenter) and sequenced with an Illumina HiSeq 2500.
Proteomics
50ml of frozen pellets from three biological replicates of each strain in embryo or L4 stage were taken for the proteomics analysis.
Proteins from the different samples were extracted by using urea buffer containing: 9M Urea, 400mM Ammonium bicarbonatee3 Cell Reports 27, 1244–1253.e1–e4, April 23, 2019
[ABC] and 10mM DTT in the ratio of 600ul buffer to 50ul sample. The samples were then sonicated on ice (7’, 10 s on/off pulse, 90%
duty) and vortexed roughly. This procedure was repeated twice. The samples were then centrifuged at 14000rpm for 10’ and 17000 g
for 10’ in order to sediment the residual cuticle debris. Then the extracted proteinswere trypsinized, and analyzed by LC-MS/MS onQ
Exactive plus (Thermo).
RIP-seq
Using worm strains containing a FLAG-ADR-1 transgene and lacking endogenous adr-1 (HH76) or lacking both endogenous adr-1
and adr-2 (HH134) and adr-1(-) (BB21) worms as a negative control, the ADR-1 RNA immunoprecipitation was performed as previ-
ously described (Washburn et al., 2014). For two biological replicates of each RIP experiment, RNA extracted from portion of the
input lysates and the immunoprecipitated RNA were subjected polyA selection using magnetic oligo-dt beads (Ambion) and a
KAPA Stranded RNA-seq Library Preparation Kit (KAPA Biosystems). Equivalent amounts of the libraries were subjected to
high-throughput sequencing on an Illumina NextSeq500 at the IU-Center for Genomics and Bioinformatics.
QUANTIFICATION AND STATISTICAL ANALYSIS
RNA editing sites and gene expression analysis
To extend the list of 30UTR edited genes, non-repetitive edited sites found by Goldstein et al. (2017) were reannotated according to
the newest Wormbase (WS261). A gene was added to the list of 30UTR edited genes if according to the new annotation it hasmultiple
editing sites in its 30UTR at the same orientation of the gene or multiple edited sites were found in proximity to the 30UTR of the gene,
less than 200bp apart, at the same orientation of the gene. At least three different biological RNA-seq samples were generated from
N2 and ADAR mutant worms (BB2, BB19, BB3 and RB886), each at embryo and L4 stage. All reads were trimmed to 47nt and iden-
tical reads were merged. Sequences were aligned to gene transcripts from WS220 (Wormbase, www.wormbase.org) using Bowtie
(Langmead et al., 2009). DESeq (Anders and Huber, 2010) package in R was used to identify differentially expressed genes. Signif-
icantly differently regulated genes were genes with at least 2-fold change in expression, with p-adj value% 0.05. P values for expres-
sion differences between 30UTR edited genes and all genes were calculated by Welch two-sample t test only for genes with p-adj
value < 0.05. P value for each mutant was calculated independently of other mutants. The Venn diagram overlap p value was calcu-
lated by hypergeometric distribution using Phyper function in R. Identification of editing sites in adr-1mutants was done essentially as
described in (Goldstein et al., 2017). The main difference is an increased stringency that a nucleotide change was selected only if it
appeared in both adr-1mutants. In short, sequences from both adr-1mutants were aligned to WS220 genome using Bowtie (Lang-
mead et al., 2009) with the restriction of not more than two alignments to exclude repetitive regions and were clustered using
Samtools (Li et al., 2009a). Nucleotide change were selected if they appeared in both adr-1mutants, with at least 5% reads aligned
to the site that contain the change and not more than 1% of reads with other nucleotide changes. Nucleotide changes were removed
if they appeared in DNA-sequences or in RNA sequences fromwormsmutated in both ADAR genes, adr-1 and adr-2 (BB21 and BB4
strains).
Proteomics analysis
The proteomics data was analyzed with MaxQuant 1.5.2.8 (Cox and Mann, 2008) versus the Caenorhabditis elegans part of the
Uniprot database. Each mutant’s sample data was analyzed against the WT (N2) sample and known contaminants were removed.
Only proteins that were identified with at least 2 peptides were tested for significant differences. Student t test p value threshold on
LFQ intensities was set to 0.05. Difference threshold on LFQ intensities was set to ± 0.8.
RIP-seq analysis
The RIP-seq 75 bp SE raw reads were trimmed of sequencing adapters, polyA tails, and repetitive elements using cutadapt (v1.9.1),
and aligned with STAR (v2.4.0i) against RepBase (v18) to remove repetitive elements. Reads were then aligned to ce10 using the
following STAR parameters: [outFilterMultimapNmax 10, outFilterScoreMinOverLread: 0.66, outFilterMatchN-minOverLread: 0.66,
outFilterMismatchNmax: 10, outFilterMismatchNoverLmax: 0.3]. Read sorting and indexing was performed using Samtools 1.3.1.
Gene expression was quantified with featureCounts (v1.5.0) using reads that map to exons. Raw read counts were input into DESeq2
(v1.18.1) to quantify differential expression for each IP/input pair using three replicates for the input samples and two replicates for the
IP per condition. One IP replicate clustered independently by batch rather than genotype and therefore was removed from the final
analysis. Genes enriched in IP were selected with a BH corrected p value less than 0.05 and a log2 fold change greater than
0.5. Genes that are enriched in both ADR-1 samples (FLAG-ADR-1 in adr-1(-) and FLAG-ADR-1 in adr-1(-);adr-2(-)) and not in the
negative control sample (adr-1(-)) were called as ADR-1 bound targets.
DATA AND SOFTWARE AVAILABILITY
The sequence data from this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/
geo/) under accession number GSE110701.Cell Reports 27, 1244–1253.e1–e4, April 23, 2019 e4
